Abstract
One of the main stumbling blocks in devising effective treatment of radiotherapy-induced nausea and vomiting (RINV) has been a lack of consensus on the emetic potential of different radiotherapy techniques and doses. The literature that is available suggests that extent of irradiation is one of the major determinants of risk for RINV.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Feyer P, Maranzano M, Molassiotis A, et al. Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO Guideline for Antiemetics in Radiotherapy: update 2009. Support Care Cancer. 2011(suppl 1):S5-S14.
Kris MG, Hesketh PJ, Somerfield MR, et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol. 2006;24:2932-47.
Enblom A, Bergius Axelsson B, Steineck G, et al. One third of patients with radiotherapyinduced nausea consider their antiemetic treatment insufficient. Support Care Cancer. 2009;17:23-32.
Maranzano E, De Angelis V, Pergolizzi S, et al. Radiation-induced emesis (RIE): results of the second observational multicenter Italian trial. Radiother Oncol. 2010;1:36-41.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2013 Springer Healthcare
About this chapter
Cite this chapter
Aapro, M., Jordan, K., Feye, P. (2013). Risk Factors Associated with Nausea and Vomiting After Radiotherapy. In: Prevention of Nausea and Vomiting in Cancer Patients. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-58-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-907673-58-0_4
Published:
Publisher Name: Springer Healthcare, Tarporley
Print ISBN: 978-1-908517-87-6
Online ISBN: 978-1-907673-58-0
eBook Packages: MedicineMedicine (R0)